Benign Prostatic Hyperplasia Medications. Two types of drugs are used to treat BPH: 5-alpha-reductase inhibitors and alpha-1-adrenergic blockers. BASIC OPTION “MANAGED NOT COVERED” DRUGS “MANAGED NOT COVERED” DRUGS Basic Option “Managed Not Covered” drugs are excluded from Medications used in the management of bladder dysfunction include cholinergic agonists, alpha-adrenergic blocking agents, anticholinergic agents, tricyclic antidepressants (TCAs), and sympathomimetic agents. Treatment for Male Incontinence. Treatment for male incontinence depends on the underlying cause, the age and overall health of the patient, and the severity of the condition. Pictures of Avodart (Dutasteride), drug imprint information, side effects for the patient. Due to a nationwide drug shortage, patients receiving Buspirone and Hydroxyzine Pamoate may experience a delay in receiving their medications. Avodart (dutasteride) is a synthetic 4-azasteroid compound that is a selective inhibitor of both the type 1 and type 2 isoforms of steroid 5 alpha-reductase used to treat benign prostatic hyperplasia in men with an enlarged prostate. If left untreated, BPH can cause other medical complications such as bladder stones, bladder hypertonia, and urinary tract infections, all of which will further worsen the difficulty experienced with urination. Urinary urgency is the sudden urge to urinate, due to involuntary contractions of the bladder muscle. Urinary urgency is one of the hallmark symptoms of urinary tract infection and can be related to other conditions, as well. Benign prostatic hyperplasia Highlights. Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland becomes enlarged. The size of the gland does not necessarily predict symptom severity.